Cargando…

Development of Monoclonal Antibodies in China: Overview and Prospects

Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents. Yet, current research concentrates on technology itself and pays attention to developed countries. This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mao-Yu, Lu, Jin-Jian, Wang, Liang, Gao, Zi-Chao, Hu, Hao, Ung, Carolina Oi Lam, Wang, Yi-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355554/ https://www.ncbi.nlm.nih.gov/pubmed/25811022 http://dx.doi.org/10.1155/2015/168935

Ejemplares similares

Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China
por: Zhang, Mao-Yu, et al.
Publicado: (2015)

Building an innovation system of medical devices in China: Drivers, barriers, and strategies for sustainability
por: Cheong, Sok Teng, et al.
Publicado: (2020)

Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
por: Hu, Yuqi, et al.
Publicado: (2020)

Evaluation of the association between presenteeism and perceived availability of social support among hospital doctors in Zhejiang, China
por: Xi, Xiaoyu, et al.
Publicado: (2020)

Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives
por: Yao, Dongning, et al.
Publicado: (2020)

Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research
por: Xue, Yan, et al.
Publicado: (2023)

Policy Interventions, Development Trends, and Service Innovations of Internet Hospitals in China: Documentary Analysis and Qualitative Interview Study
por: Lai, Yunfeng, et al.
Publicado: (2021)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Exploratory study on development challenges of maternal and child healthcare institutions in China: a qualitative study combining interviews and focus groups
por: Tang, Daisheng, et al.
Publicado: (2019)

Doctor’s presenteeism and its relationship with anxiety and depression: a cross-sectional survey study in China
por: Xi, Xiaoyu, et al.
Publicado: (2019)

Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2020)

Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience
por: Ung, Carolina Oi Lam, et al.
Publicado: (2017)

Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data
por: Li, Meng, et al.
Publicado: (2018)

Consumers’ Perceptions About Pharmaceutical Care Provided by Community Pharmacists in China in Relation to Over-the-Counter Drugs: A Qualitative Study
por: Chen, Hong, et al.
Publicado: (2018)

Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China
por: Yang, Lisong, et al.
Publicado: (2020)

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
por: Liang, Zuanji, et al.
Publicado: (2021)

Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions
por: Lin, Annie Xianghong, et al.
Publicado: (2018)

Factors Contributing to Patients' Preferences for Primary Health Care Institutions in China: A Qualitative Study
por: Zhang, Weiwei, et al.
Publicado: (2020)

An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review
por: Shi, Junnan, et al.
Publicado: (2019)

Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use
por: Liang, Zuanji, et al.
Publicado: (2021)

Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model
por: Hu, Yuqi, et al.
Publicado: (2020)

Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies
por: Ung, Carolina Oi Lam, et al.
Publicado: (2022)

Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak
por: Ung, Carolina Oi Lam
Publicado: (2020)

Corrigendum to: Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2022)

Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010
por: Song, Yan, et al.
Publicado: (2014)

Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015
por: Zhang, Jingyuan, et al.
Publicado: (2019)

Development and Validation of a Logic Model for Utilization of Nutrition Support among Patients with Cancer
por: Pang, Ngou In, et al.
Publicado: (2020)

Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
por: Shi, Junnan, et al.
Publicado: (2023)

Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China
por: Lai, Yunfeng, et al.
Publicado: (2022)

Community pharmacists’ perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China
por: Song, Menghuan, et al.
Publicado: (2017)

Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model
por: Li, Meng, et al.
Publicado: (2021)

Community Pharmacists' Perceptions about Pharmaceutical Care of Traditional Medicine Products: A Questionnaire-Based Cross-Sectional Study in Guangzhou, China
por: Chen, Xi, et al.
Publicado: (2016)

Obstacles and opportunities in Chinese pharmaceutical innovation
por: Ni, Jingyun, et al.
Publicado: (2017)

Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials
por: Liang, Zuanji, et al.
Publicado: (2021)

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics
por: Bernardini, Roberto, et al.
Publicado: (2022)

Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
por: Zou, Huimin, et al.
Publicado: (2022)

The short-term associations of chronic obstructive pulmonary disease hospitalizations with meteorological factors and air pollutants in Southwest China: a time-series study
por: Li, Meng, et al.
Publicado: (2021)

Burnout among healthcare providers: Its prevalence and association with anxiety and depression during the COVID-19 pandemic in Macao, China
por: Zheng, Yu, et al.
Publicado: (2023)

Involving systems thinking and implementation science in pharmacists’ emerging role to facilitate the safe and appropriate use of traditional and complementary medicines
por: Harnett, Joanna E., et al.
Publicado: (2020)

Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis
por: Yan, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kq3vrc02suoejulqvlqsuid7mt